The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire for patients with Bone Metastases: The EORTC QLQ-BM22

作者: Edward Chow , Amanda Hird , Galina Velikova , Colin Johnson , Linda Dewolf

DOI: 10.1016/J.EJCA.2008.11.013

关键词:

摘要: Aim The aim of this study was to develop a bone metastases module supplement the European Organisation for Research and Treatment Cancer Core Questionnaire (EORTC QLQ-C30) or EORTC QLQ-C15-PAL patients with metastases. Methods Phases 1–2 development were conducted in Canada, Australia Germany according QOL group guidelines. Phase 3 nine countries seven languages. Results Sixty-one health-related quality life (HRQOL) issues generated from health care professionals (n = 152) 413). This resulted 22-item provisional module. Further testing 170 QLQ-BM22 module, containing 22 items, conceptualised into both symptom scales, five painful sites three pain characteristics, also functional eight interference six psychosocial aspects. Conclusion provides comprehensive HRQOL measurement tool future trials, which will continue undergo further validation.

参考文章(21)
David Cella, Mehul K Soni, Quality of life and symptom measures in oncology: an overview The American Journal of Managed Care. ,vol. 8, ,(2002)
Allan Lipton, Richard L. Theriault, Gabriel N. Hortobagyi, Joseph Simeone, Robert D. Knight, Kathleen Mellars, Dirk J. Reitsma, Maika Heffernan, John J. Seaman, Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases: long term follow-up of two randomized, placebo-controlled trials. Cancer. ,vol. 88, pp. 1082- 1090 ,(2000) , 10.1002/(SICI)1097-0142(20000301)88:5<1082::AID-CNCR20>3.0.CO;2-Z
I.J Diel, J.-J Body, M.R Lichinitser, E.D Kreuser, W Dornoff, V.A Gorbunova, M Budde, B Bergström, Improved quality of life after long-term treatment with the bisphosphonate ibandronate in patients with metastatic bone disease due to breast cancer. European Journal of Cancer. ,vol. 40, pp. 1704- 1712 ,(2004) , 10.1016/J.EJCA.2004.03.025
A Bottomley, S Vachalec, K Bjordal, J Blazeby, H Flechtner, P Ruyskart, The development and utilisation of the European Organisation for research and treatment of cancer quality of life group item bank. European Journal of Cancer. ,vol. 38, pp. 1611- 1614 ,(2002) , 10.1016/S0959-8049(02)00125-9
Angelique T.M. van Holten-Verzantvoort, Aeilko H. Zwinderman, Neil K. Aaronson, Jo Hermans, Beatrix van Emmerik, Frits S.A.M. van Dam, Birgit van den Bos, Olav L.M. Bijvoet, Frans J. Cleton, The effect of supportive pamidronate treatment on aspects of quality of life of patients with advanced breast cancer European Journal of Cancer and Clinical Oncology. ,vol. 27, pp. 544- 549 ,(1991) , 10.1016/0277-5379(91)90212-V
OP Purohit, C Anthony, CR Radstone, J Owen, RE Coleman, High-dose intravenous pamidronate for metastatic bone pain British Journal of Cancer. ,vol. 70, pp. 554- 558 ,(1994) , 10.1038/BJC.1994.344
G Velikova, J Weis, MJ Hjermstad, M Kopp, P Morris, M Watson, O Sezer, EORTC Quality of Life Group, The EORTC QLQ-HDC29: a supplementary module assessing the quality of life during and after high-dose chemotherapy and stem cell transplantation. European Journal of Cancer. ,vol. 43, pp. 87- 94 ,(2007) , 10.1016/J.EJCA.2006.09.004
B. Kristensen, B. Ejlertsen, M. Groenvold, S. Hein, H. Loft, H. T. Mouridsen, Oral clodronate in breast cancer patients with bone metastases: a randomized study Journal of Internal Medicine. ,vol. 246, pp. 67- 74 ,(1999) , 10.1046/J.1365-2796.1999.00507.X
M. A. G. Sprangers, A. Cull, K. Bjordal, M. Groenvold, N. K. Aaronson, , The European Organization for Research and treatment of cancer approach to quality of life assessment: guidelines for developing questionnaire modules Quality of Life Research. ,vol. 2, pp. 287- 295 ,(1993) , 10.1007/BF00434800
H.P. Sleeboom, S.E. Papapoulos, A.T.M. van Holten-Verzantvoort, J. Hermans, L.V.A.M. Beex, G. Blijham, F.J. Cleton, B.C.F. van Eck-Smit, Does supportive pamidronate treatment prevent or delay the first manifestation of bone metastases in breast cancer patients European Journal of Cancer. ,vol. 32, pp. 450- 454 ,(1996) , 10.1016/0959-8049(95)00564-1